NXTC · NextCure, Inc.
$7.68
-0.14 (-1.79%)
At close · Sep 8
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our expectation to incur additional operating losses and negative operating cash flows in the future and the need for additional funding to support our planned operations raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these unaudited financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$35.79M
Shares
4.58M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding NXTC
19 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Invesco DWA NASDAQ Momentum ETF | — | 8,307 | $355,124 | 0.70% | Long | 2020-01-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 123,276 | $197,242 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 16,250 | $100,750 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 33,566 | $53,706 | 0.00% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 3,997 | $24,781 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 3,634 | $22,531 | 0.00% | Long | 2026-05-31 | |
| Dimensional U.S. Small Cap ETF | DFAS | 2,392 | $22,030 | 0.00% | Long | 2026-04-30 | |
| Nomura Healthcare Fund | — | 12,500 | $20,000 | 0.00% | Long | 2026-06-30 | |
| iShares Micro-Cap ETF | IWC | 9,851 | $15,762 | 0.00% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 2,047 | $12,691 | 0.00% | Long | 2026-05-31 | |
| U.S. CORE EQUITY 1 PORTFOLIO | DFEOX | 1,047 | $9,643 | 0.00% | Long | 2026-04-30 | |
| Dimensional US Core Equity 1 ETF | DCOR | 822 | $7,571 | 0.00% | Long | 2026-04-30 | |
| U.S. CORE EQUITY 2 PORTFOLIO | DFQTX | 733 | $6,751 | 0.00% | Long | 2026-04-30 | |
| Ultra-Small Company Market Fund | BRSIX | 3,000 | $4,800 | 0.00% | Long | 2026-06-30 | |
| Defiance Nasdaq Junior Biotechnology ETF | — | 630 | $4,246 | 0.06% | Long | 2021-09-30 | |
| U.S. Social Core Equity 2 Portfolio | — | 307 | $2,827 | 0.00% | Long | 2026-04-30 | |
| iShares Evolved U.S. Innovative Healthcare ETF | — | 372 | $1,600 | 0.00% | Long | 2022-07-31 | |
| 1290 VT Micro Cap Portfolio | — | 741 | $1,186 | 0.00% | Long | 2026-06-30 | |
| Diversified Equity Alpha Master Portfolio | — | 689 | $1,102 | 0.00% | Long | 2026-06-30 |
Showing 1–19 of 19 positions
Key facts
CIK
1661059
CUSIP
65343E207
13F (30d)
27 filings
27 filers
Visit website
Investor relations